Articles On Alchemia (ASX:ACL)

The Australian Competition and Consumer Commission (ACCC) is wary of the possible market impact if two of the country's largest pathology companies Australian Clinical Labs Limited (ASX: ACL) and Healius (ASX: HLS) join forces, particularly...

BPH Global about to ramp up China business ACL faces ACCC resistance on proposed takeover of Healius   BPH Global to expand China business Health & wellness stock BPH Global (ASX:BP8) rose 20% after flagging a potential ramp up in Chi...

The Australian Competition and Consumer Commission (ACCC) has dealt a blow to ACL’s (ACL) proposed acquisition of Healius (HLS), highlighting preliminary competition concerns over the merger. The ACCC released a statement of issues today...

If you’re on the lookout for bargain buys, then you may want to check out Australian Clinical Labs Ltd (ASX: ACL) shares. That’s because one fund manager believes the ASX 300 healthcare stock is trading at a mouth-watering discount. Th...

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

A bid from Australian Clinical Labs (ASX: ACL) to merge with pathology services business Healius (ASX: HLS) has escalated into a slinging match, with the suitor now claiming the target is ‘failing’ shareholders by not recommending its $1.58...

There is an impression among many investors that big riches can only be achieved with ASX growth shares. But that can’t be further from the truth. There are multiple paths to the promised land. The fact is that strong returns are possible...

The ASX boards are home to hundreds of shares. And many of them pay out dividends to their investors every year. The relationship between the dividends per share that a company pays and the price that a company’s shares trade at produces t...

ShareCafeWeaker financial sector hits markets: Google and Alphabet rise afterhours                    Stocks slid Tuesday after First Republic Bank’s earnings report reignited concerns about the broader sector. Pressure on the sector...

The Australian Ethical Investment has divested its Lendlease holding The ESG-focused fundie explains why it invests in certain sectors The AEF also provides some ASX stock recommendations for ethical investors   ESG-focused fund manager A...

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Tribeca Inve...

There’s a little-known ASX All Ords share currently trading on a staggering 20% gross trailing dividend yield. This company is a small-cap among ASX healthcare shares with a market capitalisation of $712 million. It’s pathology services...

Healius (HLS) is dealt a blow as the Takeovers Panel decides against conducting proceedings over Australian Clinical Labs’ (ACL) off-market proposal last month Healius, Australia’s second-largest pathology provider, says there are “a num...

The conditions of a $1.58 billion bid from Australian Clinical Labs (ASX: ACL) are ‘overly restrictive and burdensome’ according to target Healius Limited (ASX: HLS), which has approached the Takeovers Panel for intervention in the matter....

ASX healthcare shares have underperformed the broader market since the pandemic-induced market lows in March 2020. Over the last three years, the S&P/ASX 200 Healthcare index has returned just 5.5% per year compared to the S&P/ASX 2...

Healius (HLS) reaffirms its “no action” stance to shareholders in relation to an off-market takeover bid from Australian Clinical Labs (ACL) on March 20 ACL says the merger, if it comes to fruition, could create Australia’s largest patho...

The ASX finished flattish on Monday Energy stocks lagged, while Utilities and Real Estate led There’s a host of key releases in Australia this week, including CPI data on Wednesday   The ASX 200 closed flattish on Monday with losses in th...

ShareCafeDeutsche Bank the latest international bank to tumble                    Stocks rose Friday after a volatile trading session. Although Friday began with fears that the banking crisis was spilling over to Deutsche Bank, the ma...

ASX health stocks fall 0.9% in the past five days Healius receives a $1.52 billion takeover offer from Australian Clinical Labs Pharmaceutical wholesaler Sigma reports improved performance for the financial year Healthcare and life scien...

The S&P/ASX 200 Index (ASX: XJO) is having a disappointing session on Thursday. In afternoon trade, the benchmark index is down 0.7% to 6,966.7 points. Four ASX shares that are not letting that hold them back are listed below. Here’...

ShareCafeASX closes 1.38% lower as investors digest Credit Suisse takeover by Peter Milios   On Monday, at the closing bell, the S&P/ASX 200 was 1.38 per cent lower at 6,898.50, as investors considered the takeover of Credit Suisse and...

Australian Clinical Labs has put an offer to Healius to swap shares in an off-market takeover offer. The post Healius [ASX:HLS] Receives Buyout Offer from ACL [ASX:ACL] appeared first on Money Morning Australia.

ASX accelerated losses in the afternoon, closing over 1% lower Healthcare stock Healius gets takeover bid from a much smaller company Market places 25% chance the Fed will pause this week   The ASX 200 index finished almost 1.5% lower on...

Australian Clinical Labs (ASX: ACL) has lobbed a $1.58 billion off-market offer to merge with one of its biggest competitors, Healius (ASX: HLS), as it looks to become the nation's largest pathology services provider and secure a deal that...

The S&P/ASX 200 Index (ASX: XJO) has started the week deep in the red. At the time of writing, the benchmark index is down 0.7% to 6,945.3 points. Four ASX shares that are not letting that hold them back today are listed below. Here’...

Healius gets takeover offer from ALC, a company more than half its size Neurotech will launch Phase 2 clinical trial in Rett Syndrome Germany allows Invex to commence the IIH EVOLVE Phase 3 clinical trial   Healius gets takeover offer fro...

The Healius Ltd (ASX: HLS) share price has jumped after receiving a takeover offer from Australian Clinical Labs Limited (ASX: ACL). Healius and ACL are two of the largest pathology businesses in Australia. Merger offer ACL announced this m...

The Australian Clinical Labs Ltd (ASX: ACL) share price is having a solid start to the week. In morning trade, the ASX All Ords healthcare share is up 3% to $3.73. Why is the ASX All Ords healthcare share rising? The catalyst for this has...

The Healius Ltd (ASX: HLS) share price is defying the market weakness and pushing higher on Monday. At the time of writing, the healthcare company’s shares are up 7% to $2.97. Why is the Healius share price pushing higher? Investors have...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

With much uncertainty hanging over both consumers and businesses, stock picking at the moment is a fraught activity. However, there could be a pretty straightforward method to spot ASX shares worthy of buying. Some stocks took off during l...

The end of the week is drawing near, and with it comes a massive day for ASX shares and their earnings. Some of the largest companies across healthcare, industrials, and utilities are reporting their latest figures. Which will be showered...

ShareCafe3 Small Caps Set for Long-Term Success by Simon Conn and Marc Whittaker   Calendar year 2022 was a difficult one for investors in the small cap sector of the market – with the ASX Small Ordinaries index falling -20.4% over the year...

Although — or maybe because — small-cap ASX shares were absolutely hammered in 2022, some experts are tipping a roaring comeback in 2023. IML portfolio managers Simon Conn and Marc Whittaker are certainly in this camp and specifically like...

If you want to buy a car, you try to look for the best price.  Who in their right mind would want to pay $50,000 if they can purchase the same vehicle for $40,000? So it’s irrational when investors are put off by ASX shares that have recen...

S&P/ASX 200 Index (ASX: XJO) healthcare shares saw a very mixed performance during the COVID-19 years of 2021 and 2022. But will 2023 be a stronger year? For a few names, the pandemic saw elevated earnings. COVID testing produced a lot...

Sure, it’s been a frightening time for investors. But 2022 has also been an opportunity to pick up some absolute bargains as quality ASX shares end up heavily discounted. With this in mind, it’s prudent to see which stocks have fallen rad...

The ASX is up 0.50% with Energy leading the way Energy stocks gain as coal plays led again The European Central Bank (ECB) will announce its rates decision today   Aussie shares rose half a percent on Thursday to a 6-week high, with all s...

Highlights The S&P/ASX 200 closed marginally up on Thursday (27 October 2022), gaining 41.40 points or 0.61% to close at 6,852.30 points. Nine out of eleven sectors ended higher. Energy sector lead the gains as it closed 2.34% up,...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At the time of writing, the benchmark index is up 0.55% to 6,847.4 points. Four ASX shares that have failed to follow the market higher today ar...

The Australian Clinical Labs Ltd (ASX: ACL) share price is crashing deep into the red on Thursday. In morning trade, the pathology services provider’s shares are down 12% to $3.12. Why is the Australian Clinical Labs share price sinking?...

Australian Clinical Labs (ASX: ACL) owned Medlab Pathology has joined a growing list of companies impacted by cyber attacks after revealing a data breach has affected the health records and credit card information of almost 223,000 people,...

ShareCafeUS markets rise as EV battery integration grows rapidly under Biden Administration                    US equities were mostly higher in fairly choppy Wednesday trading. The Nasdaq Composite ground higher in choppy trading on...

When investing in times of economic uncertainty like now, it can help to think of the brands you use on a day-to-day basis. If you and millions of Australians are already regularly using the products and services, that demand may well rema...

With ASX reporting season in full swing, S&P/ASX 200 Index (ASX: XJO) shares are declaring dividends left, right, and centre. Once dividends are declared, there’s a cut-off date to determine which shareholders are entitled to the upc...

We’re well and truly in the thick of ASX reporting season. The biggest names in the All Ordinaries Index (ASX: XAO) are unveiling their financial results. And many are declaring lucrative dividends. With that comes an important date: the...

ShareCafeEnergy crisis playing out across the globe                    US equities finished lower in Monday trading, ending near the worst levels. Investors are anticipating what could be a volatile week of trading ahead of Federal Re...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is a sea of red and down heavily. At the time of writing, the benchmark index is down 4.25% to 6,634.7 points. Four ASX shares that have defied the odds and pushed higher are listed...

Highlights XAO or All Ords entails the 500 largest companies on the ASX XAO is down by nearly 5.19% on a YTD basis, as of 7 June 2022 The healthcare space has witnessed great developments amid the COVID-19 outbreak. The All Ordina...

IDX snaps up QLD-based radiology group for circa $38m  NSB starts HREC review process  Credit Suisse downgrades HLS, initiates coverage of ACL   Integral Diagnostics Limited (ASX:IDX) says it’s agreed to terms with Queensland-based Exact...